| Dr Harel Simon, DMD | |
|
416 N Bedford Dr, Suite #404, Beverly Hills, CA 90210-4322 | |
| (310) 275-6236 | |
| Not Available |
| Full Name | Dr Harel Simon |
|---|---|
| Gender | Male |
| Speciality | Dentist - Prosthodontics |
| Location | 416 N Bedford Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013306430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0700X | Dentist - Prosthodontics | 50098 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harel Simon, DMD 416 N Bedford Dr, Suite #404, Beverly Hills, CA 90210-4322 Ph: (310) 275-6236 | Dr Harel Simon, DMD 416 N Bedford Dr, Suite #404, Beverly Hills, CA 90210-4322 Ph: (310) 275-6236 |
News Archive
EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.
Technology Commercialization Group, LLC (TCG), a healthcare consultancy based in Research Triangle Park, North Carolina has signed an agreement to represent Optimapharm d.o.o., as it enters the US market.
Helix BioPharma Corp. today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix's positive findings from its preliminary non-GLP toxicology studies.
Children with known skin, food and respiratory allergies should be screened for an emerging, chronic food allergy called eosinophilic esophagitis, a painful inflammation of the esophagus, the food tube between the mouth and stomach.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.
› Verified 1 days ago
Xuan Yue, Dentist Medicare: Not Enrolled in Medicare Practice Location: 8920 Wilshire Blvd Ste 406, Beverly Hills, CA 90211 Phone: 310-854-1845 | |
Dr. Leyli Dehghan Shirazi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 436 N Roxbury Dr Ste 109, Beverly Hills, CA 90210 Phone: 310-385-1311 Fax: 310-385-1377 | |
Gabriel Gabbaypour, DDS MD Dentist Medicare: Accepting Medicare Assignments Practice Location: 465 N Roxbury Drive, #815, Beverly Hills, CA 90210 Phone: 310-276-1155 Fax: 310-276-1418 | |
Jason V Kboudi, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 8641 Wilshire Blvd Ste 205, Beverly Hills, CA 90211 Phone: 310-626-1212 Fax: 310-626-0111 | |
Dr. Kathryn Michele Kashfian, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 630 North Elm Dr., Beverly Hills, CA 90210 Phone: 818-519-4177 | |
Dr. David Scott Frey, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 465 N Roxbury Dr Ste 701, Beverly Hills, CA 90210 Phone: 310-276-4537 Fax: 310-276-4538 | |
Paul Michael Gauthier, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 462 N Linden Dr # 419, Beverly Hills, CA 90212 Phone: 310-276-2993 Fax: 310-276-9593 |